Prostate Cancer

Showing NaN - NaN of 62

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Canada (drug, procedure, radiation)

Terminated
  • Prostate Cancer
  • Calgary, Canada
  • +12 more
Mar 31, 2020

Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)

Completed
  • Prostate Cancer
  • Birmingham, Alabama
  • +268 more
Mar 12, 2020

Prostate Cancer Trial in Canada, United States (3D-CRT)

Completed
  • Prostate Cancer
  • 3D-CRT
  • Birmingham, Alabama
  • +227 more
Jan 8, 2020

Prostate Cancer Trial in Worldwide (Orteronel, Prednisone, Orteronel Placebo)

Completed
  • Prostate Cancer
  • Anchorage, Alaska
  • +78 more
Nov 28, 2018

Prostate Cancer Trial in Worldwide (Abiraterone acetate, Placebo, Prednisone)

Completed
  • Prostate Cancer
  • Abiraterone acetate
  • +2 more
  • Birmingham, Alabama
  • +134 more
May 24, 2018

Prostate Cancer Trial in Canada, United States (flutamide, Zoladex, Lupron)

Completed
  • Prostate Cancer
  • Birmingham, Alabama
  • +238 more
May 15, 2018

Prostate Cancer Trial in Edmonton (Telephone Implementation Intention, Self-completed implementation intention)

Completed
  • Prostate Cancer
  • Telephone Implementation Intention
  • Self-completed implementation intention
  • Edmonton, Alberta, Canada
    University of Alberta
May 1, 2018

Prostate Cancer, Sexual Dysfunction Trial in Canada, United States (Tadalafil, Placebo)

Completed
  • Prostate Cancer
  • Sexual Dysfunction
  • Birmingham, Alabama
  • +191 more
Jan 18, 2018

Prostate Cancer Trial in Australia, Canada, France (7800 cGy/39 fractions in 8 weeks, 6000 cGy/20 fractions in 4 weeks)

Completed
  • Prostate Cancer
  • 7800 cGy/39 fractions in 8 weeks
  • 6000 cGy/20 fractions in 4 weeks
  • Liverpool, New South Wales, Australia
  • +24 more
Jul 28, 2017

Prostate Cancer Trial in Canada (bicalutamide, goserelin acetate, clinical observation)

Completed
  • Prostate Cancer
  • Calgary, Alberta, Canada
  • +13 more
Mar 3, 2017

Prostate Shape DuringProstate Seed Implant

Unknown status
  • Prostate Cancer
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Jan 23, 2017

    Prostate Cancer Trial in Canada (vandetanib, Placebo)

    Terminated
    • Prostate Cancer
    • Calgary, Alberta, Canada
    • +10 more
    Oct 27, 2016

    Prostate Cancer Trial in Worldwide (Custirsen, Docetaxel, Prednisone)

    Completed
    • Prostate Cancer
    • Birmingham, Alabama
    • +139 more
    Oct 13, 2016

    Prostate Cancer Trial in Worldwide (cabazitaxel, prednisone, custirsen sodium)

    Completed
    • Prostate Cancer
    • Marina Del Rey, California
    • +93 more
    Oct 11, 2016

    Prostate Cancer Trial in Edmonton (3T MR Spectroscopy)

    Completed
    • Prostate Cancer
    • 3T MR Spectroscopy
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Jul 14, 2016

    Prostate Cancer Trial in Canada (Goserelin Acetate)

    Completed
    • Prostate Cancer
    • Goserelin Acetate
    • Edmonton, Alberta, Canada
    • +10 more
    Jul 8, 2016

    Prostate Cancer Trial in Edmonton (3T MR Imaging, C-Choline PET Scanning, Gene Rearrangement)

    Completed
    • Prostate Cancer
    • 3T MR Imaging
    • +2 more
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Jul 4, 2016

    Prostate Cancer Trial in Edmonton (Tomotherapy)

    Unknown status
    • Prostate Cancer
    • Tomotherapy
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Jul 4, 2016

    Prostate Cancer Trial in Edmonton (Permanent prostate implant)

    Completed
    • Prostate Cancer
    • Permanent prostate implant
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Mar 14, 2016

    Normal Tissue Radiation Injury in Patients Treated for Breast,

    Unknown status
    • Breast Cancer
    • +5 more
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Mar 14, 2016

      Blood Test to Measure DNA Damage in Blood

      Terminated
      • Prostate Cancer
      • Blood test
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Feb 24, 2016

      Genomic, Proteomic and Dosimetric Determinants of Late Toxicity

      Terminated
      • Prostate Cancer
        • Edmonton, Alberta, Canada
          Cross Cancer Institute
        Feb 24, 2016

        Osteoporosis in Advanced Prostate Cancer Treated With Hormonal

        Completed
        • Prostate Cancer
        • Osteoporosis
          • Edmonton, Alberta, Canada
            Cross Cancer Institute
          Feb 24, 2016

          Prostate Cancer Trial in Edmonton (Magnetic Resonance Spectroscopy (3Tesla))

          Completed
          • Prostate Cancer
          • Magnetic Resonance Spectroscopy (3Tesla)
          • Edmonton, Alberta, Canada
            Cross Cancer Institute
          Feb 24, 2016

          Serum Prostate Specific Antigen After Radiotherapy

          Completed
          • Prostate Cancer
            • Edmonton, Alberta, Canada
              Cross Cancer Institute
            Feb 23, 2016